Crossmark

PRMT1 promotes the tumor suppressor function of p14 <sup>ARF</sup> and is indicative for pancreatic cancer prognosis

Crossref DOI link: https://doi.org/10.15252/embj.2020106777

Published Online: 2021-05-17

Published Print: 2021-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Repenning, Antje

Happel, Daniela

Bouchard, Caroline

Meixner, Marion

Verel‐Yilmaz, Yesim

Raifer, Hartmann

Holembowski, Lena

Krause, Eberhard

Kremmer, Elisabeth

Feederle, Regina https://orcid.org/0000-0002-3981-367X
Keber, Corinna U

Lohoff, Michael

Slater, Emily P

Bartsch, Detlef K

Bauer, Uta‐Maria https://orcid.org/0000-0003-1344-9117
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (BA 1467/6)

Deutsche Forschungsgemeinschaft (BA 2292/5)

Deutsche Forschungsgemeinschaft (TRR81 A03)

Deutsche Forschungsgemeinschaft (SFB1213 A06)

Deutsche Forschungsgemeinschaft (BA 2292/1)

Deutsche Forschungsgemeinschaft (BA 2292/4)
License Information

Version of Record valid from 2021-05-17
More Information

Publication History

Received: 2020-09-12

Accepted: 2021-04-01

Published: 2021-05-17